PDF herunterladen
The Journal of Hip Surgery 2019; 03(03): 142-150
DOI: 10.1055/s-0039-1693422
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Osteonecrosis of the Femoral Head: Can Arthroplasty be Avoided—A Brief Review of Common Interventions

Thomas A. Einhorn
1   Department of Orthopedic Surgery, NYU Langone Health, Langone Orthopedic Hospital, New York
,
Afshin A. Anoushiravani
2   Department of Orthopaedic Surgery, Albany Medical Center, Albany, New York
,
Kevin K. Chen
1   Department of Orthopedic Surgery, NYU Langone Health, Langone Orthopedic Hospital, New York
,
Thomas Draper
2   Department of Orthopaedic Surgery, Albany Medical Center, Albany, New York
,
Tony Tsismenakis
1   Department of Orthopedic Surgery, NYU Langone Health, Langone Orthopedic Hospital, New York
,
Richard Iorio
1   Department of Orthopedic Surgery, NYU Langone Health, Langone Orthopedic Hospital, New York
› Institutsangaben
Weitere Informationen

Publikationsverlauf

07. Mai 2018

18. April 2019

Publikationsdatum:
30. Juli 2019 (online)

    Lizenzen und Reprints

Abstract

Osteonecrosis of the femoral head (ONFH) is a rapidly progressive degenerative disease frequently affecting individuals within their fourth and fifth decade of life. Though often asymptomatic, patients with ONFH may present with a wide range of symptoms, including deep groin pain. There are many classification systems used to stratify disease severity, of which the Association of Research Circulation Osseous (ARCO) classification system is currently the most comprehensive. Once diagnosed, an estimated 75% of patients will experience femoral head collapse within three years of diagnosis if left untreated. Currently, the only definitive intervention available for ONFH is total hip arthroplasty (THA). However, recent advancements have been made with respect to the available treatment modalities. In this article, the author review the management of ONFH, providing clinicians with the necessary information to counsel their patients.

Keywords

osteonecrosis of the femoral head - bone marrow aspirate concentrate - stem cells - core decompression - bisphosphonates - hyperbaric oxygen therapy - shockwave therapy - vascularized fibular grafts - vascularized iliac grafts
 

  • References

  • 1 Lieberman JR, Berry DJ, Mont MA. , et al. Osteonecrosis of the hip: management in the 21st century. Instr Course Lect 2003; 52: 337-355
    PubMedGoogle Scholar
  • 2 Merle D'Aubigné R, Postel M, Mazabraud A, Massias P, Gueguen J, France P. Idiopathic necrosis of the femoral head in adults. J Bone Joint Surg Br 1965; 47 (04) 612-633
    CrossrefPubMedGoogle Scholar
  • 3 Ficat RP, Arlet J. Forage-biopsie de la tete femorale dans I'osteonecrose primative. Observations histo-pathologiques portant sur huit forages. Rev Rhum 1964; (31) 257-264
    PubMedGoogle Scholar
  • 4 Ficat RP. Idiopathic bone necrosis of the femoral head. Early diagnosis and treatment. J Bone Joint Surg Br 1985; 67 (01) 3-9
    PubMedGoogle Scholar
  • 5 Smith SW, Meyer RA, Connor PM, Smith SE, Hanley Jr EN. Interobserver reliability and intraobserver reproducibility of the modified Ficat classification system of osteonecrosis of the femoral head. J Bone Joint Surg Am 1996; 78 (11) 1702-1706
    CrossrefPubMedGoogle Scholar
  • 6 Nishii T, Sugano N, Miki H, Hashimoto J, Yoshikawa H. Does alendronate prevent collapse in osteonecrosis of the femoral head?. Clin Orthop Relat Res 2006; 443 (443) 273-279
    CrossrefPubMedGoogle Scholar
  • 7 Jw G. A new international classification of osteonecrosis of the ARCO Committee on terminology and classification. J Jpn Orthop Assoc. 1992; 66: 18-20
    PubMedGoogle Scholar
  • 8 Schmitt-Sody M, Kirchhoff C, Mayer W, Goebel M, Jansson V. Avascular necrosis of the femoral head: inter- and intraobserver variations of Ficat and ARCO classifications. Int Orthop 2008; 32 (03) 283-287
    CrossrefPubMedGoogle Scholar
  • 9 Agarwala S, Jain D, Joshi VR, Sule A. Efficacy of alendronate, a bisphosphonate, in the treatment of AVN of the hip. A prospective open-label study. Rheumatology (Oxford) 2005; 44 (03) 352-359
    CrossrefPubMedGoogle Scholar
  • 10 Mont MA, Cherian JJ, Sierra RJ, Jones LC, Lieberman JR. Nontraumatic osteonecrosis of the femoral head: where do we stand today? A ten-year update. J Bone Joint Surg Am 2015; 97 (19) 1604-1627
    CrossrefPubMedGoogle Scholar
  • 11 Agarwala S, Sule A, Pai BU, Joshi VR. Study of alendronate in avascular necrosis of bone. J Assoc Physicians India 2001; 49: 949-950
    PubMedGoogle Scholar
  • 12 Agarwala S, Shah S, Joshi VR. The use of alendronate in the treatment of avascular necrosis of the femoral head: follow-up to eight years. J Bone Joint Surg Br 2009; 91 (08) 1013-1018
    PubMedGoogle Scholar
  • 13 Lai KA, Shen WJ, Yang CY, Shao CJ, Hsu JT, Lin RM. The use of alendronate to prevent early collapse of the femoral head in patients with nontraumatic osteonecrosis. A randomized clinical study. J Bone Joint Surg Am 2005; 87 (10) 2155-2159
    PubMedGoogle Scholar
  • 14 Chen CH, Chang JK, Lai KA, Hou SM, Chang CH, Wang GJ. Alendronate in the prevention of collapse of the femoral head in nontraumatic osteonecrosis: a two-year multicenter, prospective, randomized, double-blind, placebo-controlled study. Arthritis Rheum 2012; 64 (05) 1572-1578
    CrossrefPubMedGoogle Scholar
  • 15 Lee YK, Ha YC, Cho YJ. , et al. Does zoledronate prevent femoral head collapse from osteonecrosis? A prospective, randomized, open-label, multicenter study. J Bone Joint Surg Am 2015; 97 (14) 1142-1148
    CrossrefPubMedGoogle Scholar
  • 16 Stulberg BN, Davis AW, Bauer TW, Levine M, Easley K. Osteonecrosis of the femoral head. A prospective randomized treatment protocol. Clin Orthop Relat Res 1991; (268) 140-151
    PubMedGoogle Scholar
  • 17 Koo KH, Kim R. Quantifying the extent of osteonecrosis of the femoral head. A new method using MRI. J Bone Joint Surg Br 1995; 77 (06) 875-880
    PubMedGoogle Scholar
  • 18 Neumayr LD, Aguilar C, Earles AN. , et al; National Osteonecrosis Trial in Sickle Cell Anemia Study Group. Physical therapy alone compared with core decompression and physical therapy for femoral head osteonecrosis in sickle cell disease. Results of a multicenter study at a mean of three years after treatment. J Bone Joint Surg Am 2006; 88 (12) 2573-2582
    CrossrefPubMedGoogle Scholar
  • 19 Hernigou P, Beaujean F. Treatment of osteonecrosis with autologous bone marrow grafting. Clin Orthop Relat Res 2002; (405) 14-23
    PubMedGoogle Scholar
  • 20 Hernigou P, Poignard A, Zilber S, Rouard H. Cell therapy of hip osteonecrosis with autologous bone marrow grafting. Indian J Orthop 2009; 43 (01) 40-45
    PubMedGoogle Scholar
  • 21 Gangji V, De Maertelaer V, Hauzeur JP. Autologous bone marrow cell implantation in the treatment of non-traumatic osteonecrosis of the femoral head: five year follow-up of a prospective controlled study. Bone 2011; 49 (05) 1005-1009
    CrossrefPubMedGoogle Scholar
  • 22 Chang T, Tang K, Tao X. , et al. Treatment of early avascular necrosis of femoral head by core decompression combined with autologous bone marrow mesenchymal stem cells transplantation [in Chinese]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2010; 24 (06) 739-743
    PubMedGoogle Scholar
  • 23 Sen RK, Tripathy SK, Aggarwal S, Marwaha N, Sharma RR, Khandelwal N. Early results of core decompression and autologous bone marrow mononuclear cells instillation in femoral head osteonecrosis: a randomized control study. J Arthroplasty 2012; 27 (05) 679-686
    CrossrefPubMedGoogle Scholar
  • 24 Tabatabaee RM, Saberi S, Parvizi J, Mortazavi SM, Farzan M. Combining concentrated autologous bone marrow stem cells injection with core decompression improves outcome for patients with early-stage osteonecrosis of the femoral head: a comparative study. J Arthroplasty 2015; 30 (9, Suppl) 11-15
    CrossrefPubMedGoogle Scholar
  • 25 Piuzzi NS, Chahla J, Jiandong H. , et al. Analysis of cell therapies used in clinical trials for the treatment of osteonecrosis of the femoral head: a systematic review of the literature. J Arthroplasty 2017; 32 (08) 2612-2618
    CrossrefPubMedGoogle Scholar
  • 26 Taylor GI, Miller GD, Ham FJ. The free vascularized bone graft. A clinical extension of microvascular techniques. Plast Reconstr Surg 1975; 55 (05) 533-544
    CrossrefPubMedGoogle Scholar
  • 27 Urbaniak JR, Coogan PG, Gunneson EB, Nunley JA. Treatment of osteonecrosis of the femoral head with free vascularized fibular grafting. A long-term follow-up study of one hundred and three hips. J Bone Joint Surg Am 1995; 77 (05) 681-694
    CrossrefPubMedGoogle Scholar
  • 28 Scully SP, Aaron RK, Urbaniak JR. Survival analysis of hips treated with core decompression or vascularized fibular grafting because of avascular necrosis. J Bone Joint Surg Am 1998; 80 (09) 1270-1275
    CrossrefPubMedGoogle Scholar
  • 29 Berend KR, Gunneson EE, Urbaniak JR. Free vascularized fibular grafting for the treatment of postcollapse osteonecrosis of the femoral head. J Bone Joint Surg Am 2003; 85-A (06) 987-993
    PubMedGoogle Scholar
  • 30 Yoo MC, Kim KI, Hahn CS, Parvizi J. Long-term followup of vascularized fibular grafting for femoral head necrosis. Clin Orthop Relat Res 2008; 466 (05) 1133-1140
    CrossrefPubMedGoogle Scholar
  • 31 Eward WC, Rineer CA, Urbaniak JR, Richard MJ, Ruch DS. The vascularized fibular graft in precollapse osteonecrosis: is long-term hip preservation possible?. Clin Orthop Relat Res 2012; 470 (10) 2819-2826
    CrossrefPubMedGoogle Scholar
  • 32 Kane SM, Ward WA, Jordan LC, Guilford WB, Hanley Jr EN. Vascularized fibular grafting compared with core decompression in the treatment of femoral head osteonecrosis. Orthopedics 1996; 19 (10) 869-872
    PubMedGoogle Scholar
  • 33 Sotereanos DG, Plakseychuk AY, Rubash HE. Free vascularized fibula grafting for the treatment of osteonecrosis of the femoral head. Clin Orthop Relat Res 1997; (344) 243-256
    PubMedGoogle Scholar
  • 34 Ligh CA, Nelson JA, Fischer JP, Kovach SJ, Levin LS. The effectiveness of free vascularized fibular flaps in osteonecrosis of the femoral head and neck: a systematic review. J Reconstr Microsurg 2017; 33 (03) 163-172
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 35 Shuler MS, Rooks MD, Roberson JR. Porous tantalum implant in early osteonecrosis of the hip: preliminary report on operative, survival, and outcomes results. J Arthroplasty 2007; 22 (01) 26-31
    CrossrefPubMedGoogle Scholar
  • 36 Gaskill TR, Urbaniak JR, Aldridge III JM. Free vascularized fibular transfer for femoral head osteonecrosis: donor and graft site morbidity. J Bone Joint Surg Am 2009; 91 (08) 1861-1867
    CrossrefPubMedGoogle Scholar
  • 37 Elmalı N, Ertem K, Karakaplan M, Pepele D, Dağgez C, Topgül H. Vascular pedicled iliac bone grafting is effective in patients with an early stage of femoral head avascular necrosis. Eklem Hastalik Cerrahisi 2014; 25 (01) 2-7
    CrossrefPubMedGoogle Scholar
  • 38 Pavlovčič V, Dolinar D, Arnež Z. Femoral head necrosis treated with vascularized iliac crest graft. Int Orthop 1999; 23 (03) 150-153
    CrossrefPubMedGoogle Scholar
  • 39 Eisenschenk A, Lautenbach M, Schwetlick G, Weber U. Treatment of femoral head necrosis with vascularized iliac crest transplants. Clin Orthop Relat Res 2001; (386) 100-105
    PubMedGoogle Scholar
  • 40 Zhao D, Xu D, Wang W, Cui X. Iliac graft vascularization for femoral head osteonecrosis. Clin Orthop Relat Res 2006; 442: 171-179
    CrossrefPubMedGoogle Scholar
  • 41 Yen C-Y, Tu YK, Ma C-H, Yu S-W, Kao F-C, Lee MS-S. Osteonecrosis of the femoral head: comparison of clinical results for vascularized iliac and fibula bone grafting. J Reconstr Microsurg 2006; 22 (01) 21-24
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 42 Chen CC, Lin CL, Chen WC, Shih HN, Ueng SWN, Lee MS. Vascularized iliac bone-grafting for osteonecrosis with segmental collapse of the femoral head. J Bone Joint Surg Am 2009; 91 (10) 2390-2394
    CrossrefPubMedGoogle Scholar
  • 43 Tay J, Levesque JP, Winkler IG. Cellular players of hematopoietic stem cell mobilization in the bone marrow niche. Int J Hematol 2017; 105 (02) 129-140
    CrossrefPubMedGoogle Scholar
  • 44 Song HJ, Lan BS, Cheng B. , et al. Treatment of early avascular necrosis of femoral head by small intestinal submucosal matrix with peripheral blood stem cells. Transplant Proc 2011; 43 (05) 2027-2032
    CrossrefPubMedGoogle Scholar
  • 45 Pak J, Lee JH, Jeon JH, Lee SH. Complete resolution of avascular necrosis of the human femoral head treated with adipose tissue-derived stem cells and platelet-rich plasma. J Int Med Res 2014; 42 (06) 1353-1362
    PubMedGoogle Scholar
  • 46 Koren L, Ginesin E, Melamed Y, Norman D, Levin D, Peled E. Hyperbaric oxygen for stage I and II femoral head osteonecrosis. Orthopedics 2015; 38 (03) e200-e205
    CrossrefPubMedGoogle Scholar
  • 47 Bosco G, Vezzani G, Mrakic Sposta S. , et al. Hyperbaric oxygen therapy ameliorates osteonecrosis in patients by modulating inflammation and oxidative stress. J Enzyme Inhib Med Chem 2018; 33 (01) 1501-1505
    CrossrefPubMedGoogle Scholar
  • 48 Vezzani G, Quartesan S, Cancellara P. , et al. Hyperbaric oxygen therapy modulates serum OPG/RANKL in femoral head necrosis patients. J Enzyme Inhib Med Chem 2017; 32 (01) 707-711
    CrossrefPubMedGoogle Scholar
  • 49 Xie K, Mao Y, Qu X. , et al. High-energy extracorporeal shock wave therapy for nontraumatic osteonecrosis of the femoral head. J Orthop Surg Res 2018; 13 (01) 25
    CrossrefPubMedGoogle Scholar
  • 50 Dedes V, Stergioulas A, Kipreos G, Dede AM, Mitseas A, Panoutsopoulos GI. Effectiveness and safety of shockwave therapy in tendinopathies. Mater Sociomed 2018; 30 (02) 131-146
    CrossrefPubMedGoogle Scholar
  • 51 Algarni AD, Al Moallem HM. Clinical and radiological outcomes of extracorporeal shock wave therapy in early-stage femoral head osteonecrosis. Adv Orthop 2018; 2018: 7410246
    PubMedGoogle Scholar
  • 52 Gangji V, Hauzeur JP, Matos C, De Maertelaer V, Toungouz M, Lambermont M. Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells. A pilot study. J Bone Joint Surg Am 2004; 86-A (06) 1153-1160
    PubMedGoogle Scholar